Radiation Applications

Belgium / BR2 Research Reactor Plays Key Role In New Clinical Procedure

By David Dalton
16 June 2021

BR2 Research Reactor Plays Key Role In New Clinical Procedure
The BR2 research reactor at Mol in Belgium.
The first clinical procedure has taken place on a patient using radioactive holmium-166 microspheres that were activated at the BR2 research reactor in Mol, Belgium, Quirem Medical said.

Want to know more?
Sign up.

Pen Use this content

Tags


Related